Skip to main content

Hunkapiller Retires from ABI, Burzik Takes the Helm

This is an updated version of an earlier story. To view the original version, click here.

NEW YORK, Aug. 23 (GenomeWeb News) - Applera said today that Michael Hunkapiller, senior vice president and president of the company's Applied Biosystems group, has retired.

The company also announced that Hunkapiller has been replaced by Catherine Burzik, former executive vice president and COO.


An Applera spokesman told GenomeWeb News that Hunkapiller's decision to retire was a personal one, adding that "the exact timing of Mike's decision to retire was his." The spokesman said that the board of directors of Applera was first made aware of Hunkapiller's plan to retire just before a regularly scheduled board meeting held late last week.


The spokesman said that Hunkapiller was not available for comment.


"The company is indebted to Mike for his many pioneering contributions over the past two decades," Tony White, CEO of Applera, said in a statement. "Cathy Burzik joined us in September 2003 from Johnson & Johnson where she was president of their Ortho-Clinical Diagnostics business. Cathy has extensive operating experience in running complex global businesses, and we look forward to her leadership and contributions to Applied Biosystems going forward," he added.


The Applera spokesman noted that Burzik would also continue to act as the interim president of ABI's molecular biology division until a replacement can be found. "That search is on right now," he said.


The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.